Literature DB >> 25207143

Effects of ozonated olive oil on acute radiation proctitis in rats.

Fatma Ayça Gültekin1, Bekir Hakan Bakkal2, Demet Sümer1, Füruzan Köktürk3, Sibel Bektaş4.   

Abstract

BACKGROUND: Acute radiation proctitis is a common complication of pelvic radiation and management of acute radiation proctitis is under evaluation. The beneficial effects of ozonated olive oil (OzOO) have already been shown in the treatment of chronic wounds. Thus, this study was designed to evaluate the therapeutic effects of topical OzOO on acute radiation proctitis. AIMS: To evaluate the therapeutic effects of topical OzOO on acute radiation proctitis. STUDY
DESIGN: Animal experimentation.
METHODS: RATS WERE DIVIDED INTO THREE GROUPS: control; irradiation+saline (1 mL); and irradiation +OzOO (1 mL). A single fraction of 17.5 Gy was delivered to each rat. The OzOO was administered rectally each day after irradiation. Each rat was observed daily for signs of proctitis. Irradiated rats were euthanised on days 5 and 10. The mucosal changes were evaluated macroscopically and pathologically.
RESULTS: According to the clinical findings, five rats in the irradiation+saline group showed Grade 4 symptoms on the 10(th) day. Macroscopic finding scores on the 10(th) day in the irradiation+saline and irradiation+OzOO groups were statistically significantly different. On pathological examination, radiation-induced mucosal damage was the most prominent 10 days after irradiation in saline-treated rats. On the 10(th) day, the irradiation+OzOO group showed mild inflammation and slight crypt change, which corresponded to Grade 1 pathological findings.
CONCLUSION: OzOO attenuates macroscopic and pathological findings of acute radiation proctitis in rats.

Entities:  

Keywords:  Ozonated olive oil; radiation proctitis

Year:  2013        PMID: 25207143      PMCID: PMC4115945          DOI: 10.5152/balkanmedj.2013.9158

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  30 in total

1.  Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate.

Authors:  R Kochhar; F Patel; A Dhar; S C Sharma; S Ayyagari; R Aggarwal; M K Goenka; B D Gupta; S K Mehta
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

2.  Intravesical ozone therapy for progressive radiation-induced hematuria.

Authors:  Bernardino Clavo; Dominga Gutiérrez; Dionisio Martín; Gerardo Suárez; María A Hernández; Francisco Robaina
Journal:  J Altern Complement Med       Date:  2005-06       Impact factor: 2.579

Review 3.  The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence.

Authors:  Scott Allen; Chris Kilian; Jenise Phelps; Harry T Whelan
Journal:  Support Care Cancer       Date:  2012-01-14       Impact factor: 3.603

4.  Factitial proctitis: a restudy at the University of Minnesota.

Authors:  L F Sherman; K A Prem; N M Mensheha
Journal:  Dis Colon Rectum       Date:  1971 Jul-Aug       Impact factor: 4.585

5.  Argon plasma coagulation has a long-lasting therapeutic effect in patients with chronic radiation proctitis.

Authors:  G Karamanolis; K Triantafyllou; Z Tsiamoulos; D Polymeros; T Kalli; N Misailidis; S D Ladas
Journal:  Endoscopy       Date:  2009-05-13       Impact factor: 10.093

Review 6.  Conservative therapies for hemorrhagic radiation proctitis: a review.

Authors:  Guilherme Cotti; Victor Seid; Sérgio Araujo; Afonso Henrique Silva e Souza; Desid rio Roberto Kiss; Angelita Habr-Gama
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  2003-11-11

7.  Effects of ozone on cellular ATP levels in rat and mouse alveolar macrophages.

Authors:  R S Oosting; M Van Rees-Verhoef; J Verhoef; L M Van Golde; L Van Bree
Journal:  Toxicology       Date:  1991       Impact factor: 4.221

8.  Radiation proctitis in the rat. Sequential changes and effects of anti-inflammatory agents.

Authors:  M G Northway; M W Scobey; K R Geisinger
Journal:  Cancer       Date:  1988-11-01       Impact factor: 6.860

9.  A rat model for radiation-induced proctitis.

Authors:  S Kan; M Chun; Y M Jin; M S Cho; Y T Oh; B O Ahn; T Y Oh
Journal:  J Korean Med Sci       Date:  2000-12       Impact factor: 2.153

10.  Ozone oxidative preconditioning: a protection against cellular damage by free radicals.

Authors:  O S León; S Menéndez; N Merino; R Castillo; S Sam; L Pérez; E Cruz; V Bocci
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more
  4 in total

1.  Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients.

Authors:  Bernardino Clavo; Norberto Santana-Rodriguez; Pedro Llontop; Dominga Gutierrez; Daniel Ceballos; Charlin Méndez; Gloria Rovira; Gerardo Suarez; Dolores Rey-Baltar; Laura Garcia-Cabrera; Gregorio Martínez-Sánchez; Dolores Fiuza
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-18       Impact factor: 2.629

2.  Evaluation of prophylactic and therapeutic effects of ruscogenin on acute radiation proctitis: an experimental rat model.

Authors:  Erkan Yavuz; Onur Olgac Karagulle; Gulcin Ercan; Atilla Celik; Hakan Yigitbas; Busra Yaprak Bayrak; Rumeysa Tartar; Ramazan Kusaslan; Yuksel Altinel; Osman Bilgin Gulcicek
Journal:  Ann Surg Treat Res       Date:  2018-03-26       Impact factor: 1.859

3.  Novel mechanisms underlying inhibition of inflammation-induced angiogenesis by dexamethasone and gentamicin via PI3K/AKT/NF-κB/VEGF pathways in acute radiation proctitis.

Authors:  Yousong Li; Qin Ding; Jinsheng Gao; Chunxia Li; Pengxiao Hou; Jie Xu; Kaiqi Cao; Min Hu; Lin Cheng; Xixing Wang; Xiaoling Yang
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

4.  Association of Ozone with 5-Fluorouracil and Cisplatin in Regulation of Human Colon Cancer Cell Viability: In Vitro Anti-Inflammatory Properties of Ozone in Colon Cancer Cells Exposed to Lipopolysaccharides.

Authors:  Vincenzo Simonetti; Vincenzo Quagliariello; Pierangela Giustetto; Marianno Franzini; Rosario Vincenzo Iaffaioli
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-04       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.